Pharmaceutical
| Sat 04 Apr 2026
Beijing, April 4 -- State Intellectual Property Office of China has received Synovation Therapeutics Inc patent application for Heterocyclic Compounds as WRN Inhibitors. Yang Zhiye, Bai Yu, He Chunhong, Zhou Fei, You Lin, Mukai Takeshi, Zheng Hewen, Li Yu, Zhang Fenglei, Qi Chao, Wu Liangxing and Yao Wenqing developed the invent..